Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy.

Proc Natl Acad Sci U S A 2007 Dec 27;104(49):19357-62. Epub 2007 Nov 27.

Prince Henry's Institute of Medical Research, Clayton, Victoria 3168, Australia.

Blastocyst implantation is a critical stage in the establishment of pregnancy. Leukemia inhibitory factor (LIF) is essential for mouse blastocyst implantation and also plays a role in human pregnancy. We examined the effect of a potent LIF antagonist (LA) on mouse implantation. In mice, LIF expression peaks on day 3.5 of pregnancy (D3.5) (D0.5 = day of mating plug detection) in the uterine glandular epithelium. LA (7 mg/kg per day) administered from D2.5 to D4.5 via four hourly i.p. injections plus continuous administration via miniosmotic pump resulted in complete implantation failure. To improve its pharmacokinetic properties, we conjugated LA to polyethylene glycol (PEG), achieving a significant increase in serum levels. PEGylated LA (PEGLA) (37.5 mg/kg per day) administered via three i.p. injections between D2.5 and D3.5 also resulted in complete implantation failure. PEGLA immunolocalized to the uterine luminal epithelium at the time of blastocyst implantation. Both LA and PEGLA reduced phosphorylation of the downstream signaling molecule STAT3 in luminal epithelial cells on D3.5. The effects of PEGLA were found to be endometrial, with no embryo-lethal effects observed. These data demonstrate that administration of a PEGylated LIF antagonist is an effective method of targeting LIF signaling in the endometrium and a promising novel approach in the development of nonhormonal contraceptives for women.

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0710110104
Publisher Site
http://dx.doi.org/10.1073/pnas.0710110104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2148294PMC
December 2007
20 Reads

Publication Analysis

Top Keywords

blastocyst implantation
12
lif antagonist
8
implantation failure
8
complete implantation
8
day administered
8
mg/kg day
8
implantation
7
lif
5
signaling molecule
4
downstream signaling
4
administered d25
4
d25 d45
4
pegla reduced
4
injections continuous
4
hourly injections
4
reduced phosphorylation
4
phosphorylation downstream
4
d45 hourly
4
epithelium mg/kg
4
glandular epithelium
4

Altmetric Statistics

References

(Supplied by CrossRef)

Sharkey et al.
Bailli  re's best practice & research. Clinical obstetrics & gynaecology 2003

Glasier et al.
Lancet 2006

Robb et al.
Journal of reproductive immunology 2002

Stewart et al.
Nature; Physical Science (London) 1992

Metcalf et al.
Stem Cells 2003

Bhatt et al.
PNAS 1991

Yang et al.
Molecular reproduction and development 1995

Chen et al.
Endocrinology 2000

Kishimoto et al.
Cell 1994

Song et al.
Reproduction 2006

PNAS 2001

Similar Publications